ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,…
Philadelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of…
UTRECHT, The Netherlands, March 6, 2025 /PRNewswire/ -- Vitestro, a pioneer in medical robotics, proudly reveals the name of its…
NEW YORK, March 6, 2025 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP), today announced they will host a panel…
BOSTON, March 6, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, and Tiefenbacher Group, a leading…
TORONTO and DALLAS, March 6, 2025 /PRNewswire/ - In advance of International Women's Day, Perimeter Medical Imaging AI, Inc. (TSXV: PINK)…
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the…
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,…
Los Angeles, California--(Newsfile Corp. - March 6, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer…
JUPITER, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),…